ACE I/D and Apo B R3500Q polymorphisms have also been associated with thrombosis and CVD since they increase the risk of MI and thrombotic episodes, whereas the ACE D/D variant has also been linked to elevated plasma levels of ACE and suppression of fibrinolysis [57,58]. The gene discussed is ACE; the disease is myocardial infarction.